knowledge -WSS

knowledge

author：explore 2025-10-01 17:20:53 - browse：1636

Illustration of a crowd of people looking toward a cityscape. — Adobe

Few public health challenges have been more daunting and persistent than the opioid crisis, which started because of egregious conduct by opioid manufacturers and now is driven by an influx of fentanyl. In my home state of New Hampshire — which has been at the forefront of this heartbreaking epidemic for more than a decade — too many promising futures have been snatched away. As we look to the next stage of bipartisan efforts to take on this challenge, we must quickly reauthorize and expand the SUPPORT Act, which expired Sept. 30. It laid a new foundation for our response to this epidemic — and now it can be used to increase access to the gold standard of treatment for addiction.

In 2018, we came together across party lines to pass the SUPPORT Act, which established vital infrastructure for communities in New Hampshire and across the country to treat addiction, help people recover, and prevent substance misuse in the first place.

While there are dozens of vital measures in this legislation, one of the most critical provisions helped expand access to medication-assisted treatment, the gold standard of addiction care. Access to this lifesaving medication, buprenorphine, has historically been limited by law and clinician reluctance, fueled by harmful stigmas surrounding addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Washington mulls new rules to avert another Change Healthcare

focus

WSS

Scientists boost immune system in aging mice by making it youthful

Achieving telehealth equity for people with hearing loss

Study says nonprofit hospitals fall short in charity care spending

Medical students need to learn the potent medicine of empathy

Stroke rates rising, especially in working

Unmasking the 'centricity' illusion in clinical trials

knowledge

knowledge

explore

The cancer drug shortage isn’t new — and neither are the solutions

Steward Health Care has deal to sell doctor network to UnitedHealth

Novavax promises a turnaround & Lilly roils the obesity market

New research sheds light on how often breast cancer is overdiagnosed

Jerome Adams on the need for new antivirals for Covid

Decentralized clinical trials need collaboration to achieve wider use

Medical leaders decry Supreme Court decision on affirmative action

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Cancer drug shortages should be causing more outrage

Unmasking the 'centricity' illusion in clinical trials

entertainment

Patient advocates debate FDA's accelerated approval process

Lawsuit challenges CMS nursing home minimum staffing rule

Food as medicine: Medically tailored meals may get standardized

Washington mulls new rules to avert another Change Healthcare

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Eliminate the waiting period for sterilization covered by Medicaid

entertainment

focus

entertainment

hotspot